LEUCINE RICH REPEAT KINASE 2 (LRRK2) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE
Application
US20260085066A1
Kind: A1
Mar 26, 2026
Inventors
Steven M. Sparks, Handing Dong, Michael Berlin
Abstract
The present disclosure relates to bifunctional compounds that cause the degradation of LRRK2; pharmaceutical compositions comprising the compounds; and methods of treating disorders associated with LRRK2, including Parkinson's Disease.
CPC Classifications
C07D 413/14
A61K 31/506
A61K 31/5377
A61K 45/06
C07D 401/14
C07D 405/14
C07D 471/10
Filing Date
2023-09-06
Application No.
19109277